This compound is primarily used in the field of targeted protein degradation, specifically for research purposes. It functions as a PROTAC (Proteolysis Targeting Chimera) molecule, designed to induce the degradation of target proteins by recruiting them to an E3 ubiquitin ligase, such as cereblon. This mechanism is particularly valuable in studying disease-related proteins that are traditionally considered "undruggable." Its application is significant in cancer research, where it helps in understanding and potentially inhibiting the activity of oncogenic proteins. Additionally, it is utilized in drug discovery to explore new therapeutic strategies by selectively degrading disease-causing proteins. Its role in chemical biology also aids in elucidating protein function and cellular pathways.